Skip to main content
Clinical Trials/IRCT201201018574N1
IRCT201201018574N1
Completed
Phase 2

Assessment of the effect of Albumin compared with Placebo on the reduction of the hematoma volume in patients with Hemorrhagic Stroke referred to Ahvaz Golestan Hospital

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Hemorrhagic Stroke.
Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria : Primary Hemorrhagic Stroke; 24 hours from symptom onset; Above 18 years old.
  • Exclusion Criteria : Hematoma volume less than 7 ml; Need surgical evacuation; Pregnancy; Lactation; Systolic blood pressure less than 100 mmHg or more than 250 mmHg; Anticoagulant or Thrombolytic therapy; Serum Creatinine more than 2 mg/dl; History of known allergy to Albumin; History of severe allergic reactions known as latex gloves; Exacerbation of congestive heart failure within the past 6 months; Acute myocardial infarction in the last 6 months.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials